Strontium-89 for palliation of bone pain
Corresponding Author
Nikos Gompakis MD, PhD
Department of Pediatrics, Aristotle University of Thessaloniki, “Hippokration” General Hospital, Greece
Department of Pediatrics, Aristotle University of Thessaloniki, “Hippokration” General Hospital, Kleanthous 10, 546 42 Thessaloniki, Greece.Search for more papers by this authorP. Triantafyllou MD
Department of Pediatrics, Aristotle University of Thessaloniki, “Hippokration” General Hospital, Greece
Search for more papers by this authorB. Sidi MD, PhD
Department of Oncology, Hippokration General Hospital, Greece
Search for more papers by this authorE.D. Koliouskas MD, PhD
Department of Oncology, Hippokration General Hospital, Greece
Search for more papers by this authorN. Salem MD, PhD
Department of Nuclear Medicine, Theagenio Institute Thessaloniki, Greece
Search for more papers by this authorK. Pistevou MD, PhD
University Department of Radiology and Oncology, Aristotle University of Thessaloniki, AXEPA Hospital, Greece
Search for more papers by this authorCorresponding Author
Nikos Gompakis MD, PhD
Department of Pediatrics, Aristotle University of Thessaloniki, “Hippokration” General Hospital, Greece
Department of Pediatrics, Aristotle University of Thessaloniki, “Hippokration” General Hospital, Kleanthous 10, 546 42 Thessaloniki, Greece.Search for more papers by this authorP. Triantafyllou MD
Department of Pediatrics, Aristotle University of Thessaloniki, “Hippokration” General Hospital, Greece
Search for more papers by this authorB. Sidi MD, PhD
Department of Oncology, Hippokration General Hospital, Greece
Search for more papers by this authorE.D. Koliouskas MD, PhD
Department of Oncology, Hippokration General Hospital, Greece
Search for more papers by this authorN. Salem MD, PhD
Department of Nuclear Medicine, Theagenio Institute Thessaloniki, Greece
Search for more papers by this authorK. Pistevou MD, PhD
University Department of Radiology and Oncology, Aristotle University of Thessaloniki, AXEPA Hospital, Greece
Search for more papers by this author
REFERENCES
- 1
Charron M,
Brown M,
Rowland P, et al.
Pain palliation with strontium-89 in children with metastatic disease.
Med Pediatr Oncol
1996;
26:
393–396.
10.1002/(SICI)1096-911X(199606)26:6<393::AID-MPO4>3.0.CO;2-C CAS PubMed Web of Science® Google Scholar
- 2 Silberstein EB, Eugene L, Saenger SR. Painful osteoblastic metastases: the role of nuclear medicine. Oncology 2001; 15: 157–163; Discussion 167–170, 174.
- 3 Laing AH, et al. Strontium-89 chloride for pain palliation in prostatic skeletal malignancy. Br J Radiol 1991; 64: 816–822.
- 4 Robinson RG, Preston DF, Schiefelbein M, et al. Strontium 89 therapy for the palliation of pain due to osseous metastases. JAMA 1995; 274: 420–424.
- 5 Baumrucker S. Palliation of painful bone metastases: Strontium-89. Am J Hosp Palliat Care 1998; 15: 113–115.
- 6 Fuster D, Herranz D, Vidal-Sicart S, et al. Usefulness of strontium-89 for bone pain palliation in metastatic breast cancer patients. Nucl Med Comm 2000; 21: 623–626.
- 7 Robinson RG, Preston DF, Baxter KG, et al. Clinical experience with strontium-89 in prostatic and breast cancer patients. Semin Oncol 1993; 20 (3 Suppl 2): 44–48.
